NCT00005934View on ClinicalTrials.gov

5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2000

Study Completion Date

June 30, 2003

Conditions
Beta Thalassemia
Interventions
DRUG

5-Azacytidine

Trial Locations (1)

20892

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00005934 - 5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia | Biotech Hunter | Biotech Hunter